An NIH study is recruiting to see if an investigational weight loss medication reduces alcohol use and improves liver health.
Recap by typeshit. Post by Facebook on Facebook.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Dr Morse claims the drug's base chain is 39 amino acids and that two added side chains push it past the 40 amino acid biologic threshold. His take, not an FDA finding.
The medical center notes GLP-1 medicines may affect insulin, birth control and thyroid medications, not just appetite.
Loading…